Wolverine Asset Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Wolverine Asset Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-147,070	Closed	-$21.3K	–	1980
2023 Q1	$21.3K	Sell	147,070 -109,930	-43%	-$11.1K	﹤0.01%	1335
2022 Q4	$15.4K	Sell	257,000 -1,000	-0.4%	-$57	﹤0.01%	1568
2022 Q3	$10K	Sell	258,000 -20,000	-7%	-$2.21K	﹤0.01%	1988
2022 Q2	$30K	Sell	278,000 -69,800	-20%	-$11.4K	﹤0.01%	1726
2022 Q1	$62K	Sell	347,800 -1,000	-0.3%	-$253	﹤0.01%	1446
2021 Q4	$111K	Buy	+348,800	New	+$110K	﹤0.01%	1337

Other funds holding DMAQR

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Wolverine Asset Management's DMAQR Position: Q2 2023 in Review

Wolverine Asset Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q2 2023, closing a stake of 147,070 shares — an estimated $21.3K sold.

Wolverine Asset Management first reported a position in DMAQR in Q4 2021 and held it in 6 quarters. The position peaked at $111K in Q4 2021. 29 funds tracked by Wall St. Rank hold DMAQR as of Q2 2023.

Wolverine Asset Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 147,070 Deep Medicine Acquisition Corp. Rights shares in Q2 2023, an estimated $21.3K.
Wolverine Asset Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 6 quarters.
Wolverine Asset Management's Deep Medicine Acquisition Corp. Rights position peaked at $111K in Q4 2021.
29 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.